0001209191-21-060895.txt : 20211019 0001209191-21-060895.hdr.sgml : 20211019 20211019161515 ACCESSION NUMBER: 0001209191-21-060895 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211015 FILED AS OF DATE: 20211019 DATE AS OF CHANGE: 20211019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schlesinger Michael A. CENTRAL INDEX KEY: 0001839441 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39956 FILM NUMBER: 211331095 MAIL ADDRESS: STREET 1: C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS STREET 2: 1001 ROUTE 202 CITY: RARITAN STATE: NJ ZIP: 08869 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ortho Clinical Diagnostics Holdings plc CENTRAL INDEX KEY: 0001828443 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 981151819 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 1001 ROUTE 202 CITY: RARITAN STATE: NJ ZIP: 08869 BUSINESS PHONE: (908) 218-8000 MAIL ADDRESS: STREET 1: 1001 ROUTE 202 CITY: RARITAN STATE: NJ ZIP: 08869 FORMER COMPANY: FORMER CONFORMED NAME: Ortho-Clinical Diagnostics Bermuda Co. Ltd. DATE OF NAME CHANGE: 20201015 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-15 0 0001828443 Ortho Clinical Diagnostics Holdings plc OCDX 0001839441 Schlesinger Michael A. C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869 0 1 0 0 EVP, GC and Secretary Ordinary Shares, $0.00001 par value 2021-10-15 4 M 0 75464 6.28 A 163101 D Ordinary Shares, $0.00001 par value 2021-10-15 4 S 0 75464 19.7314 D 87637 D Stock Option 6.28 2021-10-15 4 M 0 75464 0.00 D 2024-10-22 Ordinary Shares, $0.00001 par value 75464 218043 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4. Represents the weighted average sales price for the price increments ranging from $19.5900 to $19.9200. The stock option is fully vested and exercisable. /s/ Michael A. Schlesinger 2021-10-19